Jerome D. Goldberg

Array ( [id] => 3634409 [patent_doc_number] => 05610185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds' [patent_app_type] => 1 [patent_app_number] => 8/389845 [patent_app_country] => US [patent_app_date] => 1995-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 9367 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610185.pdf [firstpage_image] =>[orig_patent_app_number] => 389845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3522915 [patent_doc_number] => 05489607 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-06 [patent_title] => 'Use of enadoline in the treatment of benign prostatic enlargement' [patent_app_type] => 1 [patent_app_number] => 8/389526 [patent_app_country] => US [patent_app_date] => 1995-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4832 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 275 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/489/05489607.pdf [firstpage_image] =>[orig_patent_app_number] => 389526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3815823 [patent_doc_number] => 05789450 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Deuterated sevoflurane as an inhalational anesthetic' [patent_app_type] => 1 [patent_app_number] => 8/389008 [patent_app_country] => US [patent_app_date] => 1995-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2960 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789450.pdf [firstpage_image] =>[orig_patent_app_number] => 389008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591117 [patent_doc_number] => 05567738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-Naphthoquinone for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/379617 [patent_app_country] => US [patent_app_date] => 1995-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3920 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567738.pdf [firstpage_image] =>[orig_patent_app_number] => 379617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158113 [patent_doc_number] => 06114397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Gossypol for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/379872 [patent_app_country] => US [patent_app_date] => 1995-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3414 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114397.pdf [firstpage_image] =>[orig_patent_app_number] => 379872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3715920 [patent_doc_number] => 05616584 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => '1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents' [patent_app_type] => 1 [patent_app_number] => 8/378420 [patent_app_country] => US [patent_app_date] => 1995-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 13919 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616584.pdf [firstpage_image] =>[orig_patent_app_number] => 378420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661964 [patent_doc_number] => 05624925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => '1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents' [patent_app_type] => 1 [patent_app_number] => 8/378419 [patent_app_country] => US [patent_app_date] => 1995-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 13952 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624925.pdf [firstpage_image] =>[orig_patent_app_number] => 378419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3411258 [patent_doc_number] => 05461058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof' [patent_app_type] => 1 [patent_app_number] => 8/377163 [patent_app_country] => US [patent_app_date] => 1995-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3034 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/461/05461058.pdf [firstpage_image] =>[orig_patent_app_number] => 377163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3742692 [patent_doc_number] => 05786391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Regulating gene expression using retinoids with Ch.sub.2 OH or related groups at the side chain terminal position' [patent_app_type] => 1 [patent_app_number] => 8/371535 [patent_app_country] => US [patent_app_date] => 1995-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 10601 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786391.pdf [firstpage_image] =>[orig_patent_app_number] => 371535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590742 [patent_doc_number] => 05567713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'Hypoglycemic agents' [patent_app_type] => 1 [patent_app_number] => 8/370062 [patent_app_country] => US [patent_app_date] => 1995-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7070 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567713.pdf [firstpage_image] =>[orig_patent_app_number] => 370062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288573 [patent_doc_number] => 06268376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Method of prevention of prostatic carcinoma with 17.beta.-N-monosubstituted-carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones' [patent_app_type] => 1 [patent_app_number] => 8/364072 [patent_app_country] => US [patent_app_date] => 1994-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2828 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268376.pdf [firstpage_image] =>[orig_patent_app_number] => 364072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3598937 [patent_doc_number] => 05559115 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Oncogene function-inhibitory agent, method for inhibiting oncogene function, and treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/364305 [patent_app_country] => US [patent_app_date] => 1994-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 6406 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559115.pdf [firstpage_image] =>[orig_patent_app_number] => 364305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695749 [patent_doc_number] => 05618823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Glutathione as chemoprotective agent' [patent_app_type] => 1 [patent_app_number] => 8/351403 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1700 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618823.pdf [firstpage_image] =>[orig_patent_app_number] => 351403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3566265 [patent_doc_number] => 05482968 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-09 [patent_title] => 'Naphthalenylmethyl cycloalkenone acetic acids and analogs thereof useful as aldose reductase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/359774 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5088 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/482/05482968.pdf [firstpage_image] =>[orig_patent_app_number] => 359774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665753 [patent_doc_number] => 05597830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Combination chemotherapy' [patent_app_type] => 1 [patent_app_number] => 8/359488 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 1856 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597830.pdf [firstpage_image] =>[orig_patent_app_number] => 359488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3522434 [patent_doc_number] => 05489576 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-06 [patent_title] => 'Therapeutic agent for hemorrhoidal diseases' [patent_app_type] => 1 [patent_app_number] => 8/359653 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2943 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/489/05489576.pdf [firstpage_image] =>[orig_patent_app_number] => 359653 [rel_patent_id] =>[rel_patent_doc_number] =>)